Related Experiment Videos
Translation-targeted therapeutics for viral diseases
1RiboGene, Inc., Hayward, CA 94545, USA.
Gene Expression
|January 1, 1995
Summary
Viruses hijack host protein synthesis, creating distinct viral translation mechanisms. These differences offer therapeutic targets for novel antiviral drugs, similar to existing antibiotics.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Viruses depend on host cell machinery for protein synthesis.
- Viral protein synthesis exhibits unique features like internal ribosome entry sites and ribosomal frameshifting.
- Viruses can inhibit host translation and prioritize viral protein production.
Purpose of the Study:
- To explore the distinct mechanisms of viral protein synthesis compared to host-cell translation.
- To identify potential therapeutic targets within viral translation processes.
- To discuss strategies for discovering translation-targeted therapeutics for viral infections.
Main Methods:
- Comparative analysis of viral and host-cell translation.
- Examination of viral mRNA features (e.g., IRES).
- Investigation of viral strategies for preferential protein synthesis.
Main Results:
- Viral protein synthesis employs unique strategies distinct from host translation.
- Enzyme PKR (protein kinase, RNA activated) plays a role in the antiviral response and translation control.
- Distinctive viral translation features present opportunities for therapeutic intervention.
Conclusions:
- The 'battlefield' of translation between viruses and host cells offers unique therapeutic targets.
- Translation-targeted therapies, exemplified by antibiotics, can be developed for viral diseases.
- Further research into viral translation mechanisms can lead to novel antiviral drug discovery.